Siga Technologies won a U.S. | Siga Technologies won a U.S. government procurement contract worth $138 million to supply its smallpox antiviral Tpoxx.
For Apellis Pharmaceuticals, the emergence of rare but serious side effects has cast a pall over the launch of the company’s geographic atrophy med Syfovre. | While touting the “strong commercial execution” of Syfovre’s launch, Apellis’ CEO Cedric Francois, M.D., Ph.D., admitted the company has become aware of several cases of retinal vasculitis tied to…
The ill-fated launch of Biogen’s Alzheimer’s disease treatment Aduhelm raised many questions, including this: Why did the FDA sign off on the drug after an independent advisory committee recommende | A study of FDA advisory committee meetings between 2010 and 2021 shows that the regulator leaned heavily toward approval. When a panel recommended approval, the…
On Monday during a quarterly earnings call, when Biogen CEO Chris Viehbacher was asked about the company’s potential to execute M&A, he randomly offered “we’ve got, I think, about $7.3 billion | Biogen has revealed a proposal to acquire Reata Pharmaceuticals for $7.3 billion. The Texas-based rare disease specialist brings newly approved Skyclarys, the…
RESEARCH TRIANGLE PARK – Most small business owners plan to or are already using generative AI – think ChatGPT – but 44% of companies are planning to hire fewer people as the movement to embrace artificial intelligence grows, according to a new survey.
FreshBooks, a provider of financial software and surveys, conducted a survey of…
Victory Capital Management Inc. decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 9.9% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 140,373 shares of the biotechnology company's stock after selling 15,490 shares during the period. Victory Capital Management Inc. owned 0.10%…
In this episode of 'The Top Line' we replay an important show from April 28, 2023 regarding Narcan. | This week on "The Top Line," we revisit an episode on Narcan the nasal spray. It is the first naloxone product to be approved for use without a prescription.
Anheuser-Busch—the maker of Stella Artois, Budweiser and Bud Light—announced plans this week to cut hundreds of employees, amid slumping sales following right-wing blowback from its partnership with transgender social media star Dylan Mulvaney, making the brewing giant the latest U.S. company to conduct layoffs as recession fears push employers to make cuts (see Forbes’ layoff…
InnovationRx is your weekly digest of healthcare news. Sign up!
Biogen (NASDAQ:BIIB - Get Free Report) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating in a research note issued to investors on Wednesday. Other equities analysts have also issued research reports about the company. Oppenheimer raised their price target on Biogen from $350.00 to $360.00 in a research…
The life sciences industry has always generated enormous amounts of data. In a digital age, data proliferation in life sciences is more vigorous than ever, to the extent that data may be as essential to a company’s value proposition as its pipeline, products, or research and development (R&D).
It is only in more recent years,…
We aspire to transform patients’ lives by making personalized and digital medicine a reality. Powered by data science and digital technologies, we aspire to drive solutions to advance research, clinical care and patient empowerment. We believe that now, more than ever, biology and technology should come together to better meet patient needs while enabling a…